Cite

HARVARD Citation

    Banna, G. et al. (2018). Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection. Critical reviews in oncology/hematology. pp. 27-39. [Online]. 
  
Back to record